Fidelity Investments
KMTS

Fidelity Investments’s Kestra Medical Technologies KMTS Stock Holding History

Fidelity Investments’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141M Sell
5,523,647
-197,407
-3% -$4.13M 0.01% 1091
2026
Q1 		$114M Sell
5,721,054
-130,590
-2% -$3.08M 0.01% 1113
2025
Q4 		$155M Buy
5,851,644
+573,656
+11% +$14.8M 0.01% 979
2025
Q3 		$125M Buy
5,277,988
+1,582,693
+43% +$28.3M 0.01% 1075
2025
Q2 		$61.3M Buy
3,695,295
+496,251
+16% +$10.8M ﹤0.01% 1316
2025
Q1 		$79.7M Buy
+3,199,044
New +$73.5M 0.01% 1180

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments's KMTS Position: Q2 2026 in Review

Fidelity Investments reduced its Kestra Medical Technologies (KMTS) stake by 3.5% in Q2 2026, selling an estimated $4.13M and leaving 5,523,647 shares worth $141M. The position accounts for 0.01% of the portfolio, ranked #1091.

Fidelity Investments first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $155M in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Fidelity Investments held 5,523,647 shares of Kestra Medical Technologies worth $141M as of Q2 2026.
  • Fidelity Investments sold 197,407 Kestra Medical Technologies shares in Q2 2026, an estimated $4.13M.
  • Kestra Medical Technologies made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1091 holding.
  • Fidelity Investments first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Fidelity Investments's Kestra Medical Technologies position peaked at $155M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.